Dihydrotestosterone (DHT) modulates the ability of NSAIDs to induce apoptosis of prostate cancer cells

被引:3
作者
Andrews, P [1 ]
Krygier, S [1 ]
Djakiew, D [1 ]
机构
[1] Georgetown Univ, Sch Med, Dept Cell Biol, Washington, DC 20007 USA
关键词
androgen receptor; apoptosis; DHT; NSAIDs; prostate cancer;
D O I
10.1007/s00280-001-0384-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Recent evidence indicates that nonsteroidal antiinflammatory drugs (NSAIDs) are effective in the treatment and prevention of prostate cancer. In the study reported here, we investigated the ability of the steroid hormone dihydrotestosterone (DHT) to modulate NSAID-induced apoptosis of prostate cancer cells. Materials and methods: Using in vitro models of androgen-sensitive and androgen-insensitive human prostate cancer cells, we evaluated the ability of a specific cyclooxygenase-2 inhibitor (NS-398) and a nonspecific cyclooxygenase inhibitor (indomethacin) to induce apoptosis in the presence of various concentrations of DHT. Apoptosis was quantified using the TUNEL method and verified by electron microscopy. Results: We found that increasing concentrations of DHT significantly enhanced the ability of NS-398 and indomethacin to induce apoptosis of androgen-sensitive LNCaP cells. The ability of NSAIDs to induce apoptosis of androgen-insensitive PC-3 cells, however, was not affected by the presence of DHT. Higher levels of DHT in the incubation medium both before as well as following exposure to NSAIDs enhanced apoptosis of LNCaP cells. Another steroid hormone that interacts with the androgen receptor in LNCaP cells (progesterone) also promoted apoptosis of these cells. Increasing concentrations of DHT caused LNCaP cells to shift from the S and G(2)/M to the G(0)/G(1) stages of the cell cycle. Conclusions: These observations support the use of DHT in combination with NSAIDs in the treatment of prostate cancer, and indicate that DHT is an important issue to address in clinical trials of NSAIDs since androgen ablation is a common treatment for prostate cancer.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 48 条
[1]  
[Anonymous], P AM ASS CANER RES
[2]   PROSTATIC CANCER - FURTHER INVESTIGATION OF HORMONAL RELATIONSHIPS [J].
BRENDLER, H ;
CHASE, WE ;
SCOTT, WW .
ARCHIVES OF SURGERY, 1950, 61 (03) :433-440
[3]  
Butler R, 2000, CELL GROWTH DIFFER, V11, P49
[4]  
CATALONA WJ, 1994, NEW ENGL J MED, V331, P996
[5]  
Culig Z, 1997, PROSTATE, V32, P106, DOI 10.1002/(SICI)1097-0045(19970701)32:2<106::AID-PROS5>3.0.CO
[6]  
2-K
[7]  
DELAUNOIT Y, 1991, CANCER RES, V51, P5165
[8]  
DRAGO JR, 1984, J ANDROL, V5, P265
[9]   Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs) [J].
Duffy, CP ;
Elliott, CJ ;
O'Connor, RA ;
Heenan, MM ;
Coyle, S ;
Cleary, IM ;
Kavanagh, K ;
Verhaegen, S ;
O'Loughlin, CM ;
NicAmhlaoibh, R ;
Clynes, M .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (08) :1250-1259
[10]  
Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO